4
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-18-047847
Chief Commercial Officer returned 2,805 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Araya Arturo · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-08-28 | Returned to the company : show line 1 in the form | −2,805 | 5,608 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-08-28 | Grant or award : show line 2 in the form Stock Option (right to buy) | +200,000 | 200,000 | D |
Loading xslF345X03/tv501988_4.xml…